significances of ret fusion gene in non-small cell lung cancer

Clicks: 192
ID: 140917
2013
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Lung cancer is the leading cause of cancer-related death worldwide, molecular target therapy has become a hot research direction of non-small cell lung cancer (NSCLC) treatment. RET fusion gene with an identifiable clinical pathological features, is present in some subsets of lung cancer, and its treatment is effective by RET inhibitor, suggesting that RET fusion gene may be a new target for individualized treatment to the subgroup of NSCLC. This article reviews the structural characteristics of RET fusion gene and expression model in clinical samples, and treatment of NSCLC.
Reference Key
liu2013chinesesignificances Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Jingjing LIU;Minghong BI
Journal proceedings of the 10th acm multimedia systems conference, mmsys 2019
Year 2013
DOI
10.3779/j.issn.1009-3419.2013.11.11
URL
http://dx.doi.org/10.3779/j.issn.1009-3419.2013.11.11
Keywords
molecular targeted therapy Oncology including cancer and carcinogens tumors lung neoplasmsneoplasms

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.